| Year |
Citation |
Score |
| 2018 |
Wilson AM, Mazzaferri J, Bergeron E, Patskovsky S, Marcoux-Valiquette P, Costantino S, Sapieha PM, Meunier M. in vivo laser-mediated retinal ganglion cell optoporation using K1.1 conjugated gold nanoparticles. Nano Letters. PMID 30285455 DOI: 10.1021/Acs.Nanolett.8B02896 |
0.309 |
|
| 2016 |
Miloudi K, Binet F, Wilson A, Cerani A, Oubaha M, Menard C, Henriques S, Mawambo G, Dejda A, Nguyen PT, Rezende FA, Bourgault S, Kennedy TE, Sapieha P. Truncated netrin-1 contributes to pathological vascular permeability in diabetic retinopathy. The Journal of Clinical Investigation. PMID 27400127 DOI: 10.1172/Jci84767 |
0.314 |
|
| 2016 |
Wilson A, Sapieha P. Neurons and guidance cues in retinal vascular diseases. Oncotarget. PMID 26894979 DOI: 10.18632/Oncotarget.7413 |
0.457 |
|
| 2014 |
Wilson AM, Chiodo VA, Boye SL, Brecha NC, Hauswirth WW, Di Polo A. Inhibitor of apoptosis-stimulating protein of p53 (iASPP) is required for neuronal survival after axonal injury. Plos One. 9: e94175. PMID 24714389 DOI: 10.1371/Journal.Pone.0094175 |
0.635 |
|
| 2013 |
Wilson AM, Morquette B, Abdouh M, Unsain N, Barker PA, Feinstein E, Bernier G, Di Polo A. ASPP1/2 regulate p53-dependent death of retinal ganglion cells through PUMA and Fas/CD95 activation in vivo. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 2205-16. PMID 23365256 DOI: 10.1523/Jneurosci.2635-12.2013 |
0.631 |
|
| 2012 |
Almasieh M, Wilson AM, Morquette B, Cueva Vargas JL, Di Polo A. The molecular basis of retinal ganglion cell death in glaucoma. Progress in Retinal and Eye Research. 31: 152-81. PMID 22155051 DOI: 10.1016/J.Preteyeres.2011.11.002 |
0.53 |
|
| 2012 |
Wilson AM, Di Polo A. Gene therapy for retinal ganglion cell neuroprotection in glaucoma. Gene Therapy. 19: 127-36. PMID 21975466 DOI: 10.1038/gt.2011.142 |
0.653 |
|
| Show low-probability matches. |